October Pharma S.A.E (EGX:OCPH)

Market Cap	2.30B +78.5%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	13.76 +4.4%
Shares Out	12.00M
PE Ratio	13.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,387
Average Volume	3,530
Open	191.70
Previous Close	191.70
Day's Range	190.15 - 192.88
52-Week Range	90.02 - 249.88
Beta	0.11
RSI	60.72
Earnings Date	Mar 16, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.